Cancer News
Idecabtagene Vicleucel Shows Promise in High-Risk Multiple Myeloma
Apr 5, 2023 9:20:13 AM / by
Krina Patel, MD, MSc
posted in
ASH
,
idecabtagene vicleucel
0 Comments
Idecabtagene Vicleucel Shows Effectiveness and Safety in High-Risk Multiple Myeloma Patients Krina Patel MD - Synopsis below extracted from the video transcript.
Read More
All posts
Subscribe to Email Updates
Recent
Popular
Categories
Lists by Topic
ASH
(12)
MOASC
(9)
City of Hope
(6)
Interview
(5)
Lymphoma
(5)
ASCO22
(4)
B-cell Lymphoma
(3)
Chronic Lymphocytic Leukemia
(3)
Gastrointestinal Malignancies
(3)
Immunotherapy
(3)
Lung Cancer EGFR
(3)
ASCO FCR Guidelines
(2)
Breast Cancer
(2)
Kidney Cancer
(2)
Ravi Salgia
(2)
Renal Cell Carcinoma
(2)
Thoracic Oncology
(2)
UC Irvine
(2)
Acute Myeloid Leukemia
(1)
Antibody Conjugates
(1)
CAR T-cell
(1)
Ethnic Minorities
(1)
Follicular Lymphoma
(1)
HER2 low
(1)
Health Inequity
(1)
Mehrdad Mobasher
(1)
Mosunetuzumab
(1)
Multiple Myeloma
(1)
Nataliya Mar
(1)
Odronextamab
(1)
Oncocyte
(1)
Penn Medicine
(1)
SABCS
(1)
Small Cell Lung Cancer
(1)
Small Lymphocytic Leukemia
(1)
Trial Eligibility
(1)
UCSF
(1)
Urothelial Cancer
(1)
Yuan Yuan
(1)
Zanubrutinib
(1)
belzutifan
(1)
idecabtagene vicleucel
(1)
see all
Posts by Topic
ASH
(12)
MOASC
(9)
City of Hope
(6)
Interview
(5)
Lymphoma
(5)
ASCO22
(4)
B-cell Lymphoma
(3)
Chronic Lymphocytic Leukemia
(3)
Gastrointestinal Malignancies
(3)
Immunotherapy
(3)
Lung Cancer EGFR
(3)
ASCO FCR Guidelines
(2)
Breast Cancer
(2)
Kidney Cancer
(2)
Ravi Salgia
(2)
Renal Cell Carcinoma
(2)
Thoracic Oncology
(2)
UC Irvine
(2)
Acute Myeloid Leukemia
(1)
Antibody Conjugates
(1)
CAR T-cell
(1)
Ethnic Minorities
(1)
Follicular Lymphoma
(1)
HER2 low
(1)
Health Inequity
(1)
Mehrdad Mobasher
(1)
Mosunetuzumab
(1)
Multiple Myeloma
(1)
Nataliya Mar
(1)
Odronextamab
(1)
Oncocyte
(1)
Penn Medicine
(1)
SABCS
(1)
Small Cell Lung Cancer
(1)
Small Lymphocytic Leukemia
(1)
Trial Eligibility
(1)
UCSF
(1)
Urothelial Cancer
(1)
Yuan Yuan
(1)
Zanubrutinib
(1)
belzutifan
(1)
idecabtagene vicleucel
(1)
See all
Recent Posts
